BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Lactobacillus fermentum FTDC 8312 combats hypercholesterolemia via alteration of gut microbiota. ✅
Go to Publication ✅
Journal of biotechnology (J Biotechnol ) Vol: 262 Issue Pages: 75-83 Pub: 2017 Nov 20 Epub: 2017 Sep 19 Authors Lye HS , Kato T , Low WY , Taylor TD , Prakash T , Lew LC , Ohno H , Liong MT , |
|
|
Probiotic effects of Lacticaseibacillus rhamnosus 1155 and Limosilactobacillus fermentum 2644 on hyperuricemic rats. ✅
Go to Publication ✅
Frontiers in nutrition (Front Nutr ) Vol: 9 Issue Pages: 993951 Pub: 2022 Epub: 2022 Sep 30 Authors Li Y , Zhu J , Lin G , Gao K , Yu Y , Chen S , Chen L , Chen Z , Li L , |
|
|
Probiotic effects of Lacticaseibacillus rhamnosus 1155 and Limosilactobacillus fermentum 2644 on hyperuricemic rats. ✅
Go to Publication ✅
Frontiers in nutrition (Front Nutr ) Vol: 9 Issue Pages: 993951 Pub: 2022 Epub: 2022 Sep 30 Authors Li Y , Zhu J , Lin G , Gao K , Yu Y , Chen S , Chen L , Chen Z , Li L , |
|
|
Probiotic effects of Lacticaseibacillus rhamnosus 1155 and Limosilactobacillus fermentum 2644 on hyperuricemic rats. ✅
Go to Publication ✅
Frontiers in nutrition (Front Nutr ) Vol: 9 Issue Pages: 993951 Pub: 2022 Epub: 2022 Sep 30 Authors Li Y , Zhu J , Lin G , Gao K , Yu Y , Chen S , Chen L , Chen Z , Li L , |
|
|
A Mix of Potentially Probiotic Limosilactobacillus fermentum Strains Alters the Gut Microbiota in a Dose- and Sex-Dependent Manner in Wistar Rats. ✅
Go to Publication ✅
Microorganisms (Microorganisms ) Vol: 12 Issue 4 Pages: Pub: 2024 Mar 26 Epub: 2024 Mar 26 Authors Carneiro Dos Santos LA , Carvalho RDO , Cruz Neto JPR , de Albuquerque Lemos DE , de Oliveira KÁR , Sampaio KB , de Luna Freire MO , Aburjaile FF , Azevedo VAC , de Souza EL , de Brito Alves JL , |
|
|
A Mix of Potentially Probiotic Limosilactobacillus fermentum Strains Alters the Gut Microbiota in a Dose- and Sex-Dependent Manner in Wistar Rats. ✅
Go to Publication ✅
Microorganisms (Microorganisms ) Vol: 12 Issue 4 Pages: Pub: 2024 Mar 26 Epub: 2024 Mar 26 Authors Carneiro Dos Santos LA , Carvalho RDO , Cruz Neto JPR , de Albuquerque Lemos DE , de Oliveira KÁR , Sampaio KB , de Luna Freire MO , Aburjaile FF , Azevedo VAC , de Souza EL , de Brito Alves JL , |
|
|
A Mix of Potentially Probiotic Limosilactobacillus fermentum Strains Alters the Gut Microbiota in a Dose- and Sex-Dependent Manner in Wistar Rats. ✅
Go to Publication ✅
Microorganisms (Microorganisms ) Vol: 12 Issue 4 Pages: Pub: 2024 Mar 26 Epub: 2024 Mar 26 Authors Carneiro Dos Santos LA , Carvalho RDO , Cruz Neto JPR , de Albuquerque Lemos DE , de Oliveira KÁR , Sampaio KB , de Luna Freire MO , Aburjaile FF , Azevedo VAC , de Souza EL , de Brito Alves JL , |
|
|
Administration of Lactobacillus fermentum KBL375 Causes Taxonomic and Functional Changes in Gut Microbiota Leading to Improvement of Atopic Dermatitis. ✅
Go to Publication ✅
Frontiers in molecular biosciences (Front Mol Biosci ) Vol: 6 Issue Pages: 92 Pub: 2019 Epub: 2019 Sep 27 Authors Kim WK , Jang YJ , Han DH , Seo B , Park S , Lee CH , Ko G , |
|
|
Administration of Lactobacillus fermentum KBL375 Causes Taxonomic and Functional Changes in Gut Microbiota Leading to Improvement of Atopic Dermatitis. ✅
Go to Publication ✅
Frontiers in molecular biosciences (Front Mol Biosci ) Vol: 6 Issue Pages: 92 Pub: 2019 Epub: 2019 Sep 27 Authors Kim WK , Jang YJ , Han DH , Seo B , Park S , Lee CH , Ko G , |
|
|
Anti-inflammatory probiotics HF05 and HF06 synergistically alleviate ulcerative colitis and secondary liver injury. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 15 Issue 7 Pages: 3765-3777 Pub: 2024 Apr 2 Epub: 2024 Apr 2 Authors Liu C , Qi X , Liu X , Sun Y , Mao K , Shen G , Ma Y , Li Q , |
|
|
Lactobacillus fermentum 016 Alleviates Mice Colitis by Modulating Oxidative Stress, Gut Microbiota, and Microbial Metabolism. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 17 Issue 3 Pages: Pub: 2025 Jan 26 Epub: 2025 Jan 26 Authors Pan H , Yang S , Kulyar MF , Ma H , Li K , Zhang L , Mo Q , Li J , |
|
|
Lactobacillus fermentum 016 Alleviates Mice Colitis by Modulating Oxidative Stress, Gut Microbiota, and Microbial Metabolism. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 17 Issue 3 Pages: Pub: 2025 Jan 26 Epub: 2025 Jan 26 Authors Pan H , Yang S , Kulyar MF , Ma H , Li K , Zhang L , Mo Q , Li J , |
|
|
Protective Potential of Limosilactobacillus fermentum Strains and Their Mixture on Inflammatory Bowel Disease via Regulating Gut Microbiota in Mice. ✅
Go to Publication ✅
Journal of microbiology and biotechnology (J Microbiol Biotechnol ) Vol: 35 Issue Pages: e2410009 Pub: 2024 Dec 10 Epub: 2024 Dec 10 Authors Joung JY , Choi K , Lee JH , Oh NS , |
|
|
Limosilactobacillus fermentum KBL674 Alleviates Vaginal Candidiasis. ✅
Go to Publication ✅
Probiotics and antimicrobial proteins (Probiotics Antimicrob Proteins ) Vol: Issue Pages: Pub: 2024 Nov 19 Epub: 2024 Nov 19 Authors Jang SJ , Jo EJ , Lee C , Cho BR , Shin YJ , Song JS , Kim WK , Lee N , Lee H , Park S , Ko G , |
|
|
Limosilactobacillus fermentum KBL674 Alleviates Vaginal Candidiasis. ✅
Go to Publication ✅
Probiotics and antimicrobial proteins (Probiotics Antimicrob Proteins ) Vol: Issue Pages: Pub: 2024 Nov 19 Epub: 2024 Nov 19 Authors Jang SJ , Jo EJ , Lee C , Cho BR , Shin YJ , Song JS , Kim WK , Lee N , Lee H , Park S , Ko G , |
|
|
A probiotic Limosilactobacillus fermentum GR-3 mitigates colitis-associated tumorigenesis in mice via modulating gut microbiome. ✅
Go to Publication ✅
NPJ science of food (NPJ Sci Food ) Vol: 8 Issue 1 Pages: 61 Pub: 2024 Sep 6 Epub: 2024 Sep 6 Authors Zhou T , Wu J , Khan A , Hu T , Wang Y , Salama ES , Su S , Han H , Jin W , Li X , |
|
|
A probiotic Limosilactobacillus fermentum GR-3 mitigates colitis-associated tumorigenesis in mice via modulating gut microbiome. ✅
Go to Publication ✅
NPJ science of food (NPJ Sci Food ) Vol: 8 Issue 1 Pages: 61 Pub: 2024 Sep 6 Epub: 2024 Sep 6 Authors Zhou T , Wu J , Khan A , Hu T , Wang Y , Salama ES , Su S , Han H , Jin W , Li X , |
|
|
A probiotic Limosilactobacillus fermentum GR-3 mitigates colitis-associated tumorigenesis in mice via modulating gut microbiome. ✅
Go to Publication ✅
NPJ science of food (NPJ Sci Food ) Vol: 8 Issue 1 Pages: 61 Pub: 2024 Sep 6 Epub: 2024 Sep 6 Authors Zhou T , Wu J , Khan A , Hu T , Wang Y , Salama ES , Su S , Han H , Jin W , Li X , |
|
|
Lactobacillus fermentum Inhibits the Development of Colitis by Regulating the Intestinal Microbiota and Metabolites to Enhance the Intestinal Barrier and Decrease Inflammatory Responses. ✅
Go to Publication ✅
International journal of molecular sciences (Int J Mol Sci ) Vol: 26 Issue 18 Pages: Pub: 2025 Sep 19 Epub: 2025 Sep 19 Authors You X , Shi P , Liu W , Zheng M , Jin L , Liu W , |
|
|
Limosilactobacillus fermentum IOB802 Protects Against Blue Light-Induced Retinopathy via Gut Microbiota Modulation. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 17 Issue 22 Pages: Pub: 2025 Nov 11 Epub: 2025 Nov 11 Authors Liu C , Zhao Y , Li J , Gao S , Cao J , Jing N , Han X , He H , Liang W , Wang N , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
